PCAB-based triple therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PCAB-based triple therapy, covering 2022-01-14 to 2022-01-14. Get the full timeline:
Most recent: Clinical Trial Update: 14-day PCAB-based High-dose Dual Therapy and14-day PCAB-based Triple Therapy vs 14-day PPI-based Reverse Hybrid Therapy [Phase 4]